Clinical Data, Inc.
2 Thurber Boulevard
Smithfield
Rhode Island
02917
United States
Tel: 401-233-6400 or 800-345-2822
Fax: 401-233-6480 or 800-655-3526
Website: http://www.clda.com/
Email: custserv@clda.com
119 articles about Clinical Data, Inc.
-
Forest Laboratories, Inc. to Acquire Clinical Data, Inc. in $1.2 Billion Buyout
2/22/2011
-
ScinoPharm to Provide Contract Manufacturing Service for Clinical Data, Inc.'s Newly Approved Antidepressant Drug in the United States
2/8/2011
-
Transgenomic, Inc. Announces Closing of the Acquisition of Clinical Data, Inc.'s Diagnostic Business and the Closing of a $6 Million Financing
12/30/2010
-
Clinical Data, Inc. Receives Notice of IND Filing by Santen, Inc. and Upcoming $2 Million Milestone Payment for A2A Agonist Development Program Focused on Glaucoma Treatments
12/22/2010
-
Clinical Data, Inc. to Present at Deutsche Bank's 2010 BioFEST
12/8/2010
-
Clinical Data, Inc. Announces Vilazodone Data Presented at American Society of Health System Pharmacists
12/8/2010
-
Clinical Data, Inc. to Present at the 22nd Annual Piper Jaffray Health Care Conference
11/23/2010
-
Clinical Data, Inc. Files Shelf Registration Statement
11/16/2010
-
Clinical Data, Inc. Announces FAMILION(R) Data Presented at 2010 American Heart Association Meeting
11/15/2010
-
Clinical Data, Inc. Reports Second Quarter Fiscal Year 2011 Operational and Financial Results
11/9/2010
-
Clinical Data, Inc. Granted Orphan Drug Designation for PRX-8066 for Pulmonary Arterial Hypertension
11/1/2010
-
Clinical Data, Inc. to Present at the Newsmakers in the Biotech Industry Conference
10/14/2010
-
Clinical Data, Inc. Launches FAMILION(R) Genetic Test for Medical Examiners to Aid in Determining the Cause of Sudden Unexplained Death and Sudden Infant Death Syndrome
10/4/2010
-
Clinical Data, Inc. Presents Data from Phase I Studies of Stedivaze(TM) Demonstrating Safety and Tolerability in Patients with Asthma and COPD
9/24/2010
-
Clinical Data, Inc. to Present at the JMP Securities Healthcare Conference
9/21/2010
-
Clinical Data, Inc. Reports First Quarter Fiscal Year 2011 Operational and Financial Results
8/9/2010
-
Clinical Data, Inc. to Present at Upcoming Investor Conferences
7/29/2010
-
Clinical Data, Inc. Announces Closing of $32.0 Million Public Offering Including Full Exercise of Over-Allotment
6/14/2010
-
Clinical Data, Inc. Prices Public Offering of Common Stock
6/9/2010
-
Clinical Data, Inc. Announces Data Confirming the Value of FCGR3A Gene Variant in Predicting Rituximab Response in Non-Hodgkin’s Lymphoma to be Presented at American Society of Clinical Oncology
6/3/2010